Additionally, in the U.S. alone, these specific medications could generate $70 billion in revenue. That analysis is according to Evan David Seigerman, an analyst at BMO Capital Markets.
As patients begin to understand the efficacy of the medications, particularly as it relates to weight-loss, the demand will begin to rise, according to Fortune.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
